Feature

HHS’s Azar teases changes to APMs


 

Quality, not quantity, is what Department of Health & Human Services Secretary Alex M. Azar II is looking for when it comes to physicians being paid through a value-based payment arrangement.

“I am not sure that simply being in an alternative payment model, which was the metric the Obama administration used, is the one that I would find to be substantive and real in terms of transformation of our health care system,” Mr. Azar said June 20 at a forum hosted by the Washington Post.

Health & Human Services Secretary Alex M. Azar II Wikimedia Commons/WWsgConnect/CC-SA 4.0

Alex M. Azar II

The previous administration set a goal of having at least 50% of physician Medicare payments tied to quality by the end of this year. It’s first milestone of 30% by the end of 2016 was reached in March of that year.

The current administration may have had a tough time meeting the 50% goal because of changes it made to the Quality Payment Program exempted two-thirds of eligible clinicians from the Merit-Based Incentive Payment System track in 2018.

Mr. Azar said that he is working with the team at the Centers for Medicare & Medicaid Services to come up with a better way to determine whether paying for quality is effective.

“What I don’t want to do is have an approach where it’s a tag the base, hit a scorecard number,” he said. “We genuinely want to revolutionize how health care is paid for in this country in an outcome-based, health-based, non-procedure-, non-sickness-based way. We are working on that. We want to get to real concrete metrics.”

Mr. Azar also noted that the agency is working on “the concrete strategy for the Center for Medicare & Medicaid Innovation. That will also have dimensions for what we are doing within the fee-for-service program and Medicare Advantage around moving toward value-based payment arrangements.”

He praised the efforts of the Bush Administration and the Obama Administration as providing a good foundation for the transition to paying for quality and “we will build on that.”

Recommended Reading

HHS to allow insurers’ workaround on 2019 prices
MDedge Endocrinology
FDA effort focuses on approving more generic drugs
MDedge Endocrinology
DOJ won’t defend ACA from lawsuit challenging constitutionality
MDedge Endocrinology
Stop extending credit
MDedge Endocrinology
Most Medicaid enrollees exempt from work requirements
MDedge Endocrinology
‘Captain of the ship’ doctrine
MDedge Endocrinology
6 ways to reduce liability by improving doc-nurse teams
MDedge Endocrinology
Azar blames PBMs for no drop in prescription prices
MDedge Endocrinology
FDA already balances safety, access to investigational drugs
MDedge Endocrinology
Administration eases way for small businesses to buy insurance in bulk
MDedge Endocrinology